(CL) Colgate-Palmolive - Ratings and Ratios
Toothpaste, Toothbrushes, Soap, Shampoo, Detergents, Pet Food, Cleaners
CL EPS (Earnings per Share)
CL Revenue
Description: CL Colgate-Palmolive
Colgate-Palmolive Company is a multinational consumer products company operating in two main segments: Oral, Personal and Home Care, and Pet Nutrition. The company offers a diverse range of products, including oral care, personal care, home care, and pet nutrition products under various brands such as Colgate, Palmolive, Hills Science Diet, and others. The products are sold through various channels, including traditional retailers, eCommerce retailers, wholesalers, distributors, dentists, and veterinarians.
From a financial perspective, Colgate-Palmolive has a market capitalization of approximately $75.19 billion, indicating a large-cap stock. The companys price-to-earnings ratio is around 26.28, suggesting a moderate valuation. To further analyze the companys financial health, key performance indicators (KPIs) such as revenue growth, gross margin, operating margin, and dividend yield can be examined. For instance, Colgate-Palmolives revenue growth has been relatively stable, with a compound annual growth rate (CAGR) of around 2-3% over the past few years. The companys gross margin has also been steady, ranging from 55-60%. Additionally, the dividend yield is around 2-3%, indicating a relatively attractive yield for income investors.
In terms of operational performance, Colgate-Palmolives Oral, Personal and Home Care segment has been driven by the success of its oral care products, particularly toothpaste and toothbrushes. The Pet Nutrition segment has also performed well, driven by the popularity of Hills Science Diet and Prescription Diet products. To gauge the companys operational efficiency, KPIs such as return on equity (ROE), return on assets (ROA), and inventory turnover can be analyzed. For example, a high ROE indicates that the company is generating strong profits from its equity base. A detailed analysis of these KPIs can provide insights into the companys ability to maintain its market share and drive growth.
CL Stock Overview
| Market Cap in USD | 67,737m |
| Sub-Industry | Household Products |
| IPO / Inception | 1977-01-03 |
CL Stock Ratings
| Growth Rating | -0.09% |
| Fundamental | 77.5% |
| Dividend Rating | 57.8% |
| Return 12m vs S&P 500 | -31.7% |
| Analyst Rating | 3.77 of 5 |
CL Dividends
| Dividend Yield 12m | 2.35% |
| Yield on Cost 5y | 2.97% |
| Annual Growth 5y | 2.50% |
| Payout Consistency | 99.6% |
| Payout Ratio | 55.9% |
CL Growth Ratios
| Growth Correlation 3m | -81.3% |
| Growth Correlation 12m | -65.2% |
| Growth Correlation 5y | 65.7% |
| CAGR 5y | 5.77% |
| CAGR/Max DD 3y | 0.26 |
| CAGR/Mean DD 3y | 0.88 |
| Sharpe Ratio 12m | -0.62 |
| Alpha | -40.82 |
| Beta | 0.955 |
| Volatility | 17.24% |
| Current Volume | 3169.2k |
| Average Volume 20d | 4406k |
| Stop Loss | 80.7 (-3.1%) |
| Signal | -1.03 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (2.91b TTM) > 0 and > 6% of Revenue (6% = 1.20b TTM) |
| FCFTA 0.19 (>2.0%) and ΔFCFTA -1.09pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -3.90% (prev 1.48%; Δ -5.38pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.22 (>3.0%) and CFO 3.92b > Net Income 2.91b (YES >=105%, WARN >=100%) |
| Net Debt (7.54b) to EBITDA (4.80b) ratio: 1.57 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.89 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (816.5m) change vs 12m ago -0.88% (target <= -2.0% for YES) |
| Gross Margin 60.57% (prev 59.69%; Δ 0.88pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 117.8% (prev 121.3%; Δ -3.48pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 16.21 (EBITDA TTM 4.80b / Interest Expense TTM 259.0m) >= 6 (WARN >= 3) |
Altman Z'' 7.91
| (A) -0.04 = (Total Current Assets 6.00b - Total Current Liabilities 6.78b) / Total Assets 17.47b |
| (B) 1.53 = Retained Earnings (Balance) 26.73b / Total Assets 17.47b |
| warn (B) unusual magnitude: 1.53 — check mapping/units |
| (C) 0.25 = EBIT TTM 4.20b / Avg Total Assets 16.98b |
| (D) 1.48 = Book Value of Equity 24.28b / Total Liabilities 16.42b |
| Total Rating: 7.91 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.50
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 4.48% = 2.24 |
| 3. FCF Margin 16.85% = 4.21 |
| 4. Debt/Equity 12.48 = -2.50 |
| 5. Debt/Ebitda 1.83 = 0.34 |
| 6. ROIC - WACC 28.35% = 12.50 |
| 7. RoE 679.7% = 2.50 |
| 8. Rev. Trend 81.62% = 4.08 |
| 9. Rev. CAGR 5.11% = 0.64 |
| 10. EPS Trend 47.63% = 1.19 |
| 11. EPS CAGR 7.97% = 0.80 |
What is the price of CL shares?
Over the past week, the price has changed by -1.08%, over one month by -1.62%, over three months by -7.03% and over the past year by -19.24%.
Is Colgate-Palmolive a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CL is around 72.74 USD . This means that CL is currently overvalued and has a potential downside of -12.66%.
Is CL a buy, sell or hold?
- Strong Buy: 7
- Buy: 6
- Hold: 7
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the CL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 95.2 | 14.3% |
| Analysts Target Price | 95.2 | 14.3% |
| ValueRay Target Price | 81.1 | -2.6% |
Last update: 2025-09-06 04:34
CL Fundamental Data Overview
CCE Cash And Equivalents = 1.22b USD (last quarter)
P/E Trailing = 23.5028
P/E Forward = 21.1864
P/S = 3.3872
P/B = 96.4914
P/EG = 1.7081
Beta = 0.351
Revenue TTM = 20.00b USD
EBIT TTM = 4.20b USD
EBITDA TTM = 4.80b USD
Long Term Debt = 7.14b USD (from longTermDebt, last quarter)
Short Term Debt = 1.61b USD (from shortTermDebt, last quarter)
Debt = 8.76b USD (Calculated: Short Term 1.61b + Long Term 7.14b)
Net Debt = 7.54b USD (from netDebt column, last quarter)
Enterprise Value = 75.28b USD (67.74b + Debt 8.76b - CCE 1.22b)
Interest Coverage Ratio = 16.21 (Ebit TTM 4.20b / Interest Expense TTM 259.0m)
FCF Yield = 4.48% (FCF TTM 3.37b / Enterprise Value 75.28b)
FCF Margin = 16.85% (FCF TTM 3.37b / Revenue TTM 20.00b)
Net Margin = 14.55% (Net Income TTM 2.91b / Revenue TTM 20.00b)
Gross Margin = 60.57% ((Revenue TTM 20.00b - Cost of Revenue TTM 7.88b) / Revenue TTM)
Tobins Q-Ratio = 3.10 (Enterprise Value 75.28b / Book Value Of Equity 24.28b)
Interest Expense / Debt = 0.81% (Interest Expense 71.0m / Debt 8.76b)
Taxrate = 22.93% (907.0m / 3.96b)
NOPAT = 3.24b (EBIT 4.20b * (1 - 22.93%))
Current Ratio = 0.89 (Total Current Assets 6.00b / Total Current Liabilities 6.78b)
Debt / Equity = 12.48 (Debt 8.76b / last Quarter total Stockholder Equity 702.0m)
Debt / EBITDA = 1.83 (Net Debt 7.54b / EBITDA 4.80b)
Debt / FCF = 2.60 (Debt 8.76b / FCF TTM 3.37b)
Total Stockholder Equity = 428.0m (last 4 quarters mean)
RoA = 16.65% (Net Income 2.91b, Total Assets 17.47b )
RoE = 679.7% (Net Income TTM 2.91b / Total Stockholder Equity 428.0m)
RoCE = 55.45% (Ebit 4.20b / (Equity 428.0m + L.T.Debt 7.14b))
RoIC = 36.86% (NOPAT 3.24b / Invested Capital 8.78b)
WACC = 8.51% (E(67.74b)/V(76.49b) * Re(9.53%)) + (D(8.76b)/V(76.49b) * Rd(0.81%) * (1-Tc(0.23)))
Shares Correlation 3-Years: -94.60 | Cagr: -0.24%
Discount Rate = 9.53% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 74.71% ; FCFE base≈3.37b ; Y1≈3.73b ; Y5≈4.85b
Fair Price DCF = 80.32 (DCF Value 64.91b / Shares Outstanding 808.2m; 5y FCF grow 12.34% → 3.0% )
Revenue Correlation: 81.62 | Revenue CAGR: 5.11%
Rev Growth-of-Growth: -6.25
EPS Correlation: 47.63 | EPS CAGR: 7.97%
EPS Growth-of-Growth: -60.43
Additional Sources for CL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle